The One Question to Ask Before You Sign Any Healthcare Supply Chain Software Contract

Before your next vendor evaluation goes to legal review, ask this: will you run your platform on our actual item master before we sign anything?

Not a curated demo dataset. Not a sandbox that looks like your catalog. Your data, your contracts, your supplier history. If the vendor hesitates, that hesitation is your answer.

What a Demo Environment Is Designed to Hide

Most healthcare supply chain software demos follow the same script. A clean catalog. A few hundred items with complete attributes. GPO contract matches that resolve on the first try. The platform looks fast, the reporting looks sharp, and the ROI story hangs together neatly.

That environment has nothing to do with what you are actually buying.

Real item masters carry years of accumulated decisions, migrations, and workarounds. Manufacturer names that appear four different ways across five facilities. Ghost GTINs that break point-of-use scanners and push your nurses back to manual data entry. Duplicate records that split purchasing volume and silently kill tier pricing. HCPCS codes that were accurate when the record was created and retired two CMS cycles ago.

Here is the part vendors do not advertise: most matching logic looks impressive on a test set of a few hundred items. Apply that same logic to 50,000 items with real-world inconsistencies, and the match rate collapses. What looked like automated intelligence in the demo becomes a manual cleanup queue that your team inherits the week after go-live. The platform did not fail. The demo just never told you the truth about what it was being asked to do.

The Cost of Finding Out After You Sign

Bad data is not a line item. It is a leak in your bottom line, and it shows up everywhere at once.

Health systems typically achieve only 70% to 80% compliance on contracted products, meaning a significant share of purchases that should flow through negotiated pricing do not. GTIN gaps corrupt consumption data and trigger the stockout-to-emergency-freight cycle that hits the income statement directly. Missing or expired billing codes leave reimbursement uncaptured on products that are legitimately billable.

None of those problems appear in a vendor demo. All of them appear after go-live, once the platform is running against your data for the first time and your team has already absorbed six months of implementation work and a six-figure contract commitment.

At that point, you are not buying a solution. You have bought a multi-month data cleansing project your team never agreed to. The vendor moves on to the next sale. Your supply chain coordinators spend their days troubleshooting records instead of doing supply chain work.

A pre-contract trial, like a data-driven analysis, moves that discovery forward, into the evaluation stage where you still have leverage, rather than backward into implementation where the cost is yours to absorb.

What the Trial Actually Tells You

When a vendor runs your item master through their platform before you sign, the results answer questions no demo can:

Does the matching logic hold at your catalog's actual scale and complexity? Not on a curated sample. On 80,000 items with five years of inconsistent supplier name conventions across your health system.

What is your real contract alignment rate? Every vendor claims strong GPO compliance. A pre-contract trial produces a number. That number is what you are actually purchasing.

Where do the GTINs break, and what happens when they do? A platform that validates GTINs on a clean test set behaves differently on a catalog where coverage is partial and existing data includes errors.

How does the vendor respond to the gaps? A trial surfaces the items that do not resolve cleanly. What the vendor does next tells you more about the partnership than any reference call.

"But We Can't Hand Over Our Data to a Vendor We Haven't Signed With"

This is the right concern to have, and it has a straightforward answer.

A pre-contract data analysis does not require you to expose sensitive contract data before any legal framework is in place. Most trials begin under a standard Mutual NDA, which your legal team can typically turn around in days, not weeks. Data can be de-identified at the item level for the initial analysis, with full enrichment applied once basic protections are established.

The analysis is not a security risk. It is due diligence. The real risk is signing a contract without it.

What Symmetric's Item Master Audit Shows You

Symmetric offers pre-contract data assessments and analysis because our platform is built specifically for the linguistic and structural complexity of healthcare procurement data. That means normalizing supplier names against your actual contract hierarchy, not a generic reference set. It means validating GTINs against FDA registration sources and the GS1 global network at catalog scale, not on a sample.

The output is an Item Master Audit that shows you, before any commitment is made:

• GTIN coverage and validation results across your full item master

• Classification completeness and where UNSPSC gaps create spend visibility problems

• Country of Origin completeness, petroleum-derived flags, substitute availability, and more against our 1,600+ attributes

If your alignment rate is at 74% and $3 million in annual spend is flowing through at off-contract rates, you will see that number in the audit. If your GTIN coverage is creating scanning failures in three of your facilities, the audit identifies exactly where. You see what is broken, what it costs, and what the remediation plan looks like, before you sign anything.

The Question That Changes the Evaluation

Before your next software evaluation moves forward, ask every vendor on your shortlist the same question: will you run a trial analysis on our actual item master before we sign?

A vendor who says yes is confident in their platform and committed to an honest process. A vendor who redirects to a demo environment, requests a smaller sample than your actual catalog, or ties the trial to a signed contract has told you something important about the post-go-live experience.

Your item master is not a hypothetical. Your contract exposure is not a hypothetical. The platform you choose to manage both should not be evaluated on hypotheticals either.

Bring your item master. We will show you exactly what we find, and exactly what we can do about it.